Detalhe da pesquisa
1.
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
N Engl J Med
; 390(16): 1467-1480, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657244
2.
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.
Lancet Oncol
; 24(11): 1229-1241, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863088
3.
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre study.
Br J Haematol
; 202(3): 517-524, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192741
4.
A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)-associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapy.
Cytotherapy
; 25(11): 1167-1175, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480884
5.
Cytokine profiles are associated with prolonged hematologic toxicities after B-cell maturation antigen targeted chimeric antigen receptor-T-cell therapy.
Cytotherapy
; 25(2): 192-201, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496302
6.
Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy.
BMC Cancer
; 22(1): 393, 2022 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410148
7.
Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia.
Mol Ther
; 29(2): 645-657, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278564
8.
Ruxolitinib mitigates steroid-refractory CRS during CAR T therapy.
J Cell Mol Med
; 25(2): 1089-1099, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314568
9.
Toxicity and effectiveness of CD19 CAR T therapy in children with high-burden central nervous system refractory B-ALL.
Cancer Immunol Immunother
; 70(7): 1979-1993, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416942
10.
Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation.
Am J Hematol
; 96(6): 671-679, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725422
11.
Overexpression of CXCR7 accelerates tumor growth and metastasis of lung cancer cells.
Respir Res
; 21(1): 287, 2020 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33129326
12.
Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells.
Blood
; 135(26): 2425-2427, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321169
13.
Sequential CD19-22 CAR T therapy induces sustained remission in children with r/r B-ALL.
Blood
; 135(5): 387-391, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31725148
14.
Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission.
Front Immunol
; 15: 1389227, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38803489
15.
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies.
Exp Hematol Oncol
; 13(1): 28, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444007
16.
Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808074
17.
HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapy.
Bone Marrow Transplant
; 58(6): 701-709, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37002410
18.
Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies.
Blood Cancer J
; 13(1): 61, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095094
19.
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma.
Front Immunol
; 14: 1125357, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37215107
20.
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma.
Cell Transplant
; 32: 9636897231194265, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37667507